Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
warfarin tablets
DRUG
2 trials
Sponsors
Daiichi Sankyo
, Daiichi Sankyo Co., Ltd.
Conditions
Atrial Fibrillation
Embolism
Stroke
Phase 2
DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation
Completed
NCT00806624
Daiichi Sankyo Co., Ltd.
Atrial Fibrillation, Stroke
Start: 2007-10-31
End: 2009-11-30
Updated: 2019-02-26
Phase 3
Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation
Completed
NCT00781391
Daiichi Sankyo
Atrial Fibrillation, Embolism, Stroke
Start: 2008-11-30
End: 2013-05-31
Updated: 2019-03-05
Related Papers
Polygenic risk score for coronary artery disease across the spectrum of atherosclerotic disease
European Journal of Preventive Cardiology
2025-10-27
Epistaxis Versus Nonepistaxis Bleeding in Anticoagulated Patients With Atrial Fibrillation: Results From the ENGAGE AF‐TIMI 48 Trial
Journal of the American Heart Association
2025-01-10
1 citations
Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation
JAMA Cardiology
2024-07-10
21 citations
Application of the Win Ratio Method in the ENGAGE AF-TIMI 48 Trial Comparing Edoxaban With Warfarin in Patients With Atrial Fibrillation
Circulation Cardiovascular Quality and Outcomes
2024-06-03
2 citations
Serial Assessment of Biomarkers and Heart Failure Outcomes in Patients with Atrial Fibrillation
European Journal of Heart Failure
2023-03-29
12 citations
Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48
European Heart Journal - Cardiovascular Pharmacotherapy
2021-12-27
9 citations
Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation
Journal of the American College of Cardiology
2021-03-01
48 citations
Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial.
2020-12-24
83 citations
Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban Versus Warfarin in Patients With Atrial Fibrillation Based on Results of the ENGAGE AF–TIMI 48 Trial
Circulation Cardiovascular Quality and Outcomes
2020-11-01
7 citations
Left Atrial Structure and Function and the Risk of Death or Heart Failure in Atrial Fibrillation
European Journal of Heart Failure
2019-11-27
62 citations
Comparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 Trial
Circulation
2019-10-10
39 citations
Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48
Circulation
2019-01-17
138 citations
Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial
Circulation
2018-07-02
35 citations
Gastrointestinal Bleeding With Edoxaban Versus Warfarin
Circulation Cardiovascular Quality and Outcomes
2018-05-01
47 citations
Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial
Journal of the American Heart Association
2017-08-02
30 citations
Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF‐TIMI 48 Trial
Journal of the American Heart Association
2017-07-01
46 citations
Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.
2017-03-01
97 citations
Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation
Circulation Arrhythmia and Electrophysiology
2017-01-01
180 citations
Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation
JAMA Cardiology
2016-10-05
71 citations
Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 Analysis.
2016-09-01
110 citations
16 more papers not shown